Researchers from the University of Gothenburg, in collaboration with colleagues from University of Glasgow, present data that the drug Entresto (sacubitril/valsartan) which is commonly used for the treatment of cardiac failure leads to a marked reduction in plasma Aβ ratio, a candidate blood test for Alzheimer’s disease (AD).
Investigational Drug Could Help Vapers Quit
Adding daily use of the investigational drug cytisinicline to behavioral support doubled abstinence rates in e-cigarette users attempting to quit, a randomized phase II trial
May 9, 2024